Design and lead the U.S. field reimbursement team for the launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Partner with payer strategy, hub vendor, and cross-functional teams to ensure compliant patient access and reimbursement.
Own field reimbursement SOPs, budget, and team performance while capturing insights to shape market access strategy.
Capricor Therapeutics is a biotechnology company advancing transformative cell and exosome-based therapies for rare diseases. It is a publicly traded, mission-driven organization with a collaborative culture focused on scientific rigor and execution.
Serve as field market access lead for Tab-Cel launch, educating payers and sites on coverage.
Build payer relationships to enable patient access and navigate prior authorization.
Partner cross-functionally to prepare sites for reimbursement and single-case agreements.
Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and a leading European pharmaceutical firm. It offers a start-up culture with collaboration, innovation, and patient centricity.
Serve as regional expert on reimbursement and access for BridgeBio therapies.
Educate providers on benefits investigation, prior authorization, and appeals.
Coordinate patient support across hubs, pharmacies, and internal teams.
BridgeBio is a biopharmaceutical company pioneering a 'moneyball for biotech' approach to pool early-stage research and develop life-changing medicines for rare diseases. It values curiosity and experimentation, with small expert teams empowered to solve problems.